By: Carolyn A. Wilson, Ph.D., and Alice Welch, Ph.D. In 2003, two scientists in FDA’s Office of Vaccines Research and Review within the Center for Biologics Evaluation and Research (CBER) developed a pivotal step in the manufacture of a vaccine … Continue reading →